BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign

Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force

doi:10.1053/j.gastro.2021.06.076

BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign

Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force

Research output: Contribution to journal › Short survey › peer-review

36 Scopus citations

Original language	English
Pages (from-to)	1715-1717.e1
Journal	Gastroenterology
Volume	161
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2021.06.076
State	Published - 1 Nov 2021

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1053/j.gastro.2021.06.076

Cite this

@article{0fbf5bb583ee46058f5ec26bb3953814,

title = "BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign",

author = "\{Collaborators of the Maccabi Institute for Research \& Innovation COVID-19 Task Force\} and Amir Ben-Tov and Tamar Banon and Gabriel Chodick and Revital Kariv and Amit Assa and Sivan Gazit",

year = "2021",

month = nov,

day = "1",

doi = "10.1053/j.gastro.2021.06.076",

language = "English",

volume = "161",

pages = "1715--1717.e1",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "5",

}

BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign. / Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force.
In: Gastroenterology, Vol. 161, No. 5, 01.11.2021, p. 1715-1717.e1.

Research output: Contribution to journal › Short survey › peer-review

TY - JOUR

T1 - BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease

T2 - Preliminary Real-World Data During Mass Vaccination Campaign

AU - Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force

AU - Ben-Tov, Amir

AU - Banon, Tamar

AU - Chodick, Gabriel

AU - Kariv, Revital

AU - Assa, Amit

AU - Gazit, Sivan

PY - 2021/11/1

Y1 - 2021/11/1

UR - https://www.scopus.com/pages/publications/85113627006

U2 - 10.1053/j.gastro.2021.06.076

DO - 10.1053/j.gastro.2021.06.076

M3 - Short survey

C2 - 34224740

AN - SCOPUS:85113627006

SN - 0016-5085

VL - 161

SP - 1715-1717.e1

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -

BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this